ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma
Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia
Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO
Phase II Study Finds Dasatinib May Overcome ALL Resistance
Sarcoma Survivors At Risk Of Blood Clots, Study Finds
Risk of Lymphoma Increases with Hepatitis C Virus Infection
Long-Term Results Find Cisplatin Improves Survival
Study Links Ovarian Cancer To Hormone Replacement
Smokers Who Quit Live Longer Than Those Who Spit-Study
FDA Approves New Drug for Advanced Kidney Cancer
FDA Approves New Indication For Anticoagulant Frangmin
NCI-Approved Group, Center Clinical Trials Listed
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
